Postinfectious Olfactory Dysfunction: Oral Steroids and Olfactory Training versus Olfactory Training Alone: Is There any Benefit from Steroids?
- PMID: 34107478
- DOI: 10.1159/000516316
Postinfectious Olfactory Dysfunction: Oral Steroids and Olfactory Training versus Olfactory Training Alone: Is There any Benefit from Steroids?
Abstract
Introduction: There are limited treatment options for postinfectious olfactory dysfunction (PIOD). Olfactory training has recently been used in clinical practice, but no medical treatment is widely accepted. Although there is weak evidence for their value, some physicians use oral corticosteroids as first-line treatment. The aim of this study was to compare combined oral methylprednisolone and olfactory training with olfactory training alone in the management of PIOD.
Methods: This prospective cohort study included 131 patients with PIOD over a 2-year period before the COVID-19 pandemic. Seventy-eight patients who were treated with oral methylprednisolone and olfactory training (group A) were compared with 53 patients who were treated with olfactory training only (group B). Olfactory function was evaluated with "Sniffin' Sticks" at baseline and 2, 8, and 16 weeks after initial assessment. Patients who improved after steroid treatment underwent magnetic resonance imaging of the paranasal sinuses, skin prick tests, lung spirometry, and sputum eosinophil assessment.
Results: Oral steroids improved 19.23% of patients (n = 15) of group A. History, clinical evaluation, imaging, and laboratory tests identified an inflammatory background in half of them (n = 8). The remaining 7 had no findings of nasal inflammation, and all had a short history of olfactory dysfunction. Both groups significantly improved in olfactory testing results at the end of the olfactory training scheme without significant difference between them.
Conclusions: The percentage of improved patients after oral methylprednisolone was relatively low to suggest it as first-line treatment. Half of the improved patients had an underlying upper airway inflammatory condition not related to the infection that caused the acute loss of olfactory function.
Keywords: Anosmia; Olfactory training; Postinfectious olfactory dysfunction; Smell; Steroids.
© 2021 S. Karger AG, Basel.
Similar articles
-
Comparative Analysis of Olfactory and Gustatory Function of Patients With COVID-19 Olfactory Dysfunction and Non-COVID-19 Postinfectious Olfactory Dysfunction.J Korean Med Sci. 2023 Nov 6;38(43):e352. doi: 10.3346/jkms.2023.38.e352. J Korean Med Sci. 2023. PMID: 37935167 Free PMC article.
-
Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.Eur Arch Otorhinolaryngol. 2021 Aug;278(8):3113-3117. doi: 10.1007/s00405-020-06520-8. Epub 2021 Jan 9. Eur Arch Otorhinolaryngol. 2021. PMID: 33423106 Free PMC article.
-
Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction.J Allergy Clin Immunol. 2021 May;147(5):1704-1719. doi: 10.1016/j.jaci.2020.12.641. Epub 2021 Jan 13. J Allergy Clin Immunol. 2021. PMID: 33453291 Review.
-
Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study.Laryngoscope. 2014 Apr;124(4):826-31. doi: 10.1002/lary.24340. Epub 2013 Sep 19. Laryngoscope. 2014. PMID: 23929687 Clinical Trial.
-
The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.J Allergy Clin Immunol Pract. 2021 Jan;9(1):7-12. doi: 10.1016/j.jaip.2020.10.036. Epub 2020 Oct 28. J Allergy Clin Immunol Pract. 2021. PMID: 33130145 Free PMC article. Review.
Cited by
-
Therapies for COVID-19-Related Persistent Olfactory Disorders: One of the Good Fruits of the Pandemic.Pathogens. 2023 Jan 3;12(1):72. doi: 10.3390/pathogens12010072. Pathogens. 2023. PMID: 36678420 Free PMC article.
-
Characteristics of smell and taste disorders depending on etiology: a retrospective study.Eur Arch Otorhinolaryngol. 2023 Sep;280(9):4111-4119. doi: 10.1007/s00405-023-07967-1. Epub 2023 May 9. Eur Arch Otorhinolaryngol. 2023. PMID: 37160463 Free PMC article.
-
Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies.PLoS One. 2023 Aug 2;18(8):e0288285. doi: 10.1371/journal.pone.0288285. eCollection 2023. PLoS One. 2023. PMID: 37531338 Free PMC article.
-
The efficacy of olfactory training in improving olfactory function: a meta-analysis.Eur Arch Otorhinolaryngol. 2024 Oct;281(10):5267-5284. doi: 10.1007/s00405-024-08733-7. Epub 2024 May 27. Eur Arch Otorhinolaryngol. 2024. PMID: 38802578 Free PMC article.
-
Olfactory Function and Olfactory Disorders.Laryngorhinootologie. 2023 May;102(S 01):S67-S92. doi: 10.1055/a-1957-3267. Epub 2023 May 2. Laryngorhinootologie. 2023. PMID: 37130532 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical